• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新的细胞角蛋白 19mRNA 拷贝数在前哨淋巴结中的临床截断值可更好地识别适合乳腺癌腋窝淋巴结清扫术的患者。

A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer.

机构信息

Department of Health Science, School of Medicine, University of Eastern Piedmont "Amedeo Avogadro", Novara, Italy.

Department of Medical Sciences, University of Turin, Turin, Italy.

出版信息

J Clin Pathol. 2014 Aug;67(8):702-6. doi: 10.1136/jclinpath-2014-202384. Epub 2014 Jun 6.

DOI:10.1136/jclinpath-2014-202384
PMID:24906358
Abstract

AIMS

Cytokeratin 19 (CK19) mRNA copy number predicts the probability of tumour load in axillary lymph nodes (ALN) and can help in decision-making regarding the axillary dissection. The purpose of this study was to define a new cut-off of CK19 mRNA copy number using the one-step nucleic acid amplification (OSNA) assay on metastatic sentinel lymph nodes (SLN) in order to identify cases at risk of having one or more positive ALN.

METHODS

1296 SLN from 1080 patients were analysed with the OSNA assay. 194 patients with positive SLN underwent ALN dissection and the mean value of CK19 copy number (320 000) of their SLN was set as initial cut-off. Receiver operative characteristics curve identify a best cut-off of 7700 (sensitivity 78%, specificity 57%). A comparison between our and the traditional cut-off (5000) was performed.

RESULTS

The cut-off of 7700 successfully identifies patients with positive ALN (p=0.001, false- negative cases: 17%). In the range between 5000 and 7700, one patient with positive ALN would not undergo axillary dissection, whereas eight patients with negative ALN would be correctly identified.

CONCLUSIONS

We suggest that the level of CK19 mRNA copy number could be the only parameter to consider in the intraoperative management of the axilla.

摘要

目的

细胞角蛋白 19(CK19)mRNA 拷贝数可预测腋窝淋巴结(ALN)的肿瘤负荷概率,并有助于决策是否进行腋窝清扫。本研究的目的是使用一步法核酸扩增(OSNA)检测转移性前哨淋巴结(SLN)来定义 CK19 mRNA 拷贝数的新截断值,以识别具有一个或多个阳性 ALN 风险的病例。

方法

分析了 1080 例患者的 1296 个 SLN,使用 OSNA 检测。194 例阳性 SLN 患者行 ALN 清扫术,其 SLN 的 CK19 拷贝数平均值(320000)设定为初始截断值。受试者工作特征曲线确定最佳截断值为 7700(敏感性 78%,特异性 57%)。比较了我们的截断值和传统截断值(5000)。

结果

7700 的截断值成功识别出阳性 ALN 患者(p=0.001,假阴性病例:17%)。在 5000 至 7700 范围内,一个 ALN 阳性的患者将不会接受腋窝清扫术,而 8 个 ALN 阴性的患者将被正确识别。

结论

我们建议 CK19 mRNA 拷贝数水平可以成为腋窝术中管理的唯一考虑因素。

相似文献

1
A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer.新的细胞角蛋白 19mRNA 拷贝数在前哨淋巴结中的临床截断值可更好地识别适合乳腺癌腋窝淋巴结清扫术的患者。
J Clin Pathol. 2014 Aug;67(8):702-6. doi: 10.1136/jclinpath-2014-202384. Epub 2014 Jun 6.
2
The real-time intra-operative evaluation of sentinel lymph nodes in breast cancer patients using One Step Nucleic Acid Amplification (OSNA) and implications for clinical decision-making.采用一步法核酸扩增技术(OSNA)实时评估乳腺癌患者前哨淋巴结,并对临床决策的影响。
Eur J Surg Oncol. 2014 Feb;40(2):150-7. doi: 10.1016/j.ejso.2013.12.007. Epub 2013 Dec 18.
3
A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients.前哨淋巴结中细胞角蛋白19 mRNA拷贝数的截断值为2150,可能是乳腺癌患者非前哨淋巴结状态的有力预测指标。
PLoS One. 2017 Feb 10;12(2):e0171517. doi: 10.1371/journal.pone.0171517. eCollection 2017.
4
Detailed evaluation of one step nucleic acid (OSNA) molecular assay for intra-operative diagnosis of sentinel lymph node metastasis and prediction of non-sentinel nodal involvement: experience from a London teaching hospital.一步核酸(OSNA)分子检测用于前哨淋巴结转移术中诊断及非前哨淋巴结受累预测的详细评估:来自伦敦一家教学医院的经验
Breast. 2014 Aug;23(4):378-84. doi: 10.1016/j.breast.2014.02.001. Epub 2014 Mar 12.
5
Total tumor load assessed by one-step nucleic acid amplification assay as an intraoperative predictor for non-sentinel lymph node metastasis in breast cancer.通过一步核酸扩增检测评估的肿瘤总负荷作为乳腺癌非前哨淋巴结转移的术中预测指标。
Breast. 2017 Apr;32:33-36. doi: 10.1016/j.breast.2016.12.011. Epub 2016 Dec 25.
6
Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients.前哨淋巴结中总肿瘤负荷的术中分子分析:早期乳腺癌患者腋窝状态的新预测指标。
Breast Cancer Res Treat. 2013 May;139(1):87-93. doi: 10.1007/s10549-013-2524-z. Epub 2013 Apr 11.
7
Tumoral load quantification of positive sentinel lymph nodes in breast cancer to predict more than two involved nodes.乳腺癌前哨淋巴结阳性的肿瘤负荷定量以预测超过两个受累淋巴结。
Breast. 2014 Dec;23(6):859-64. doi: 10.1016/j.breast.2014.09.005. Epub 2014 Oct 3.
8
Sentinel node tumour burden quantified based on cytokeratin 19 mRNA copy number predicts non-sentinel node metastases in breast cancer: molecular whole-node analysis of all removed nodes.基于细胞角蛋白 19 mRNA 拷贝数定量的前哨淋巴结肿瘤负荷可预测乳腺癌的非前哨淋巴结转移:所有切除淋巴结的分子全淋巴结分析。
Eur J Cancer. 2013 Apr;49(6):1187-95. doi: 10.1016/j.ejca.2012.11.022. Epub 2012 Dec 19.
9
Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay.通过分子检测评估前哨淋巴结中总肿瘤负荷预测早期乳腺癌中的非前哨淋巴结转移。
Eur J Surg Oncol. 2013 Jul;39(7):766-73. doi: 10.1016/j.ejso.2013.03.011. Epub 2013 Apr 19.
10
One Step Nucleic Acid Amplification (OSNA) positive micrometastases and additional histopathological NSLN metastases: Results from a single institution over 53 months.一步核酸扩增(OSNA)检测出的微转移灶及其他组织病理学证实的前哨淋巴结转移灶:来自一家机构53个月的研究结果
Surgeon. 2016 Apr;14(2):76-81. doi: 10.1016/j.surge.2014.06.001. Epub 2014 Nov 1.

引用本文的文献

1
Application of the OSNA Technique (One-Step Nucleic Acid Amplification Test) in Breast Cancer.OSNA技术(一步核酸扩增检测)在乳腺癌中的应用
Int J Mol Sci. 2025 Jan 14;26(2):656. doi: 10.3390/ijms26020656.
2
A New Possible Cut-Off of Cytokeratin 19 mRNA Copy Number by OSNA in the Sentinel Node of Breast Cancer Patients to Avoid Unnecessary Axillary Dissection: A 10-Year Experience in a Tertiary Breast Unit.通过术中实时逆转录聚合酶链反应检测细胞角蛋白19信使核糖核酸拷贝数确定乳腺癌患者前哨淋巴结新的可能截断值以避免不必要的腋窝淋巴结清扫:一家三级乳腺中心的10年经验
Cancers (Basel). 2022 Jul 12;14(14):3384. doi: 10.3390/cancers14143384.
3
Detection of lymph node metastasis in non-small cell lung cancer using the new system of one-step nucleic acid amplification assay.
应用一步法核酸扩增检测系统检测非小细胞肺癌的淋巴结转移。
PLoS One. 2022 Mar 21;17(3):e0265603. doi: 10.1371/journal.pone.0265603. eCollection 2022.
4
Intraoperative prediction of non-sentinel lymph node metastases in breast cancer using cytokeratin 19 mRNA copy number: A retrospective analysis.利用细胞角蛋白19信使核糖核酸拷贝数对乳腺癌非前哨淋巴结转移进行术中预测:一项回顾性分析。
Mol Clin Oncol. 2022 Mar;16(3):58. doi: 10.3892/mco.2022.2491. Epub 2022 Jan 10.
5
Intraoperative Molecular Analysis of Total Tumor Load in Sentinel Lymph Node: A Predictor of Axillary Status in Early Breast Cancer.前哨淋巴结中总肿瘤负荷的术中分子分析:早期乳腺癌腋窝状态的预测因子。
Asian Pac J Cancer Prev. 2022 Jan 1;23(1):349-354. doi: 10.31557/APJCP.2022.23.1.349.
6
Can one-step nucleic acid amplification assay predict four or more positive axillary lymph node involvement in breast cancer patients: a single-centre retrospective study.一步法核酸扩增检测能否预测乳腺癌患者四个或更多阳性腋窝淋巴结转移:一项单中心回顾性研究。
Ann R Coll Surg Engl. 2022 Mar;104(3):216-220. doi: 10.1308/rcsann.2021.0154. Epub 2021 Dec 20.
7
Prognostic Significance of Lymph Node Examination by the OSNA Method in Lung Cancer Patients-Comparison with the Standard Histopathological Procedure.OSNA 法检测肺癌患者淋巴结的预后意义-与标准组织病理学检查的比较。
Cells. 2020 Dec 4;9(12):2611. doi: 10.3390/cells9122611.
8
Nomogram to predict non-sentinel lymph node status using total tumor load determined by one-step nucleic acid amplification: first report from Thailand.应用一步法核酸扩增检测总肿瘤负荷预测非前哨淋巴结状态的列线图:来自泰国的首次报告。
Breast Cancer. 2019 Jul;26(4):471-477. doi: 10.1007/s12282-019-00945-8. Epub 2019 Jan 7.
9
One-step nucleic acid amplification: the possible value in assessing sentinel lymph node metastasis during mastectomy.一步核酸扩增:在乳房切除术期间评估前哨淋巴结转移中的潜在价值。
Breast Cancer (Dove Med Press). 2018 Jan 25;10:13-21. doi: 10.2147/BCTT.S113737. eCollection 2018.
10
A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients.前哨淋巴结中细胞角蛋白19 mRNA拷贝数的截断值为2150,可能是乳腺癌患者非前哨淋巴结状态的有力预测指标。
PLoS One. 2017 Feb 10;12(2):e0171517. doi: 10.1371/journal.pone.0171517. eCollection 2017.